Bio-Techne Corp (TECH) Q2 2026 Earnings Call Highlights: Strategic Growth and Margin Expansion ... [Yahoo! Finance]
Bio-Techne Corp (TECH)
Last bio-techne corp earnings: 4/30 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.bio-techne.com
Company Research
Source: Yahoo! Finance
Total Revenue: $295.9 million, flat year-over-year on both an organic and reported basis. Adjusted Operating Margin: 31.1%, up 100 basis points year-over-year. Adjusted Gross Margin: 68.5%, down from 70.5% last year. Protein Sciences Segment Revenue: $215.1 million, organic revenue declined 1%. Diagnostics and Spatial Biology Segment Revenue: $81.2 million, 3% organic growth. Operating Cash Flow: $82.4 million. Bank Debt: $260 million, down $40 million sequentially. Cash Balance: $172.9 million. Adjusted SG&A: 29.6% of revenue, down 240 basis points from last year. R&D Expense: 7.8% of revenue, compared to 8.5% in the prior year. Net Interest Expense: $1.1 million, up $0.5 million year-over-year. Adjusted Effective Tax Rate: 22.3%, up 80 basis points year-over-year. Warning! GuruFocus has detected 5 Warning Sign with TECH. Is TECH fairly valued? Test your thesis with our free DCF calculator. Release Date: February 04, 2026 For the complete transcript of
Show less
Read more
Impact Snapshot
Event Time:
TECH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TECH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TECH alerts
High impacting Bio-Techne Corp news events
Weekly update
A roundup of the hottest topics
TECH
News
- Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge-Based Immunoassays for European Clinical Laboratories [Yahoo! Finance]Yahoo! Finance
- Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge-Based Immunoassays for European Clinical LaboratoriesPR Newswire
- Bio-Techne Announces Changes to its Leadership TeamPR Newswire
- Bio-Techne (NASDAQ:TECH) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.MarketBeat
- Bio-Techne (NASDAQ:TECH) had its price target raised by analysts at Wells Fargo & Company from $70.00 to $76.00. They now have an "overweight" rating on the stock.MarketBeat
TECH
Earnings
- 2/4/26 - Beat
TECH
Sec Filings
- 2/19/26 - Form 4
- 2/17/26 - Form 144
- 2/11/26 - Form 8-K
- TECH's page on the SEC website